Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (409) Arrow Down
Filter Results: (409) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (938)
    • Faculty Publications  (409)

    Show Results For

    • All HBS Web  (938)
      • Faculty Publications  (409)

      by Josh LernerRemove by Josh Lerner →

      ← Page 21 of 409 Results

      Are you looking for?

      →Search All HBS Web
      • October 1992 (Revised March 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (B3): Katherine Kirk

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (B3): Katherine Kirk." Harvard Business School Supplement 293-069, October 1992. (Revised March 1993.)
      • October 1992 (Revised April 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (B4): Phillip Gross

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (B4): Phillip Gross." Harvard Business School Supplement 293-070, October 1992. (Revised April 1993.)
      • October 1992 (Revised March 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (C): April 1991

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (C): April 1991." Harvard Business School Supplement 293-071, October 1992. (Revised March 1993.)
      • Research Summary

      Overview

      By: Joshua Lev Krieger
      In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is... View Details
      • Teaching Interest

      Owner/President Management Progam (Executive Education)

      By: Josh Lerner
      As business owners and entrepreneurs prepare to take their companies to the next level in a highly competitive global arena, they must be fully equipped to master a range of skills—from strategy development to financial management to team... View Details
      • Teaching Interest

      Private Equity and Venture Capital (Executive Education)

      By: Josh Lerner

      As equity markets appear to strengthen, interest rates remain low, and asset values look attractive, private equity firms are uniquely positioned to pursue new opportunities. This View Details

      • Forthcoming
      • Article

      The (Heterogenous) Economic Effects of Private Equity Buyouts

      By: Steven J. Davis, John Haltiwanger, Kyle Handley, Ben Lipsius, Josh Lerner and Javier Miranda
      The effects of private equity buyouts on employment, productivity, and job reallocation vary tremendously with macroeconomic and credit conditions, across private equity groups, and by type of buyout. We reach this conclusion by examining the most extensive... View Details
      Keywords: Private Equity Buyouts; Impact; Private Equity; Economics; Employment; Performance Productivity; Wages
      Citation
      SSRN
      Find at Harvard
      Purchase
      Related
      Davis, Steven J., John Haltiwanger, Kyle Handley, Ben Lipsius, Josh Lerner, and Javier Miranda. "The (Heterogenous) Economic Effects of Private Equity Buyouts." Management Science (forthcoming). (Pre-published online March 25, 2025. Earlier version distributed as National Bureau of Economic Research Working Paper No. 26371 and Harvard Business School Working Paper No. 20-030. Related discussion published as “Private Equity Buyout and Their Effects,” VoxEU, 2019.)
      • Teaching Interest

      Theoretical and Empirical Perspectives on Entrepreneurship (Doctoral)

      By: Josh Lerner
      Entrepreneurship—the formation and growth of new firms—is a complex phenomenon that has historically attracted relatively little academic attention. In recent years, however, scholars in a variety of disciplines have been devoting increasing attention to this topic.... View Details
      • Teaching Interest

      Venture Capital and Private Equity (MBA)

      By: Josh Lerner

      The growth of private equity internationally has been dramatic, to the point that the asset class has been both lauded as the savior and vilified as the cause of our current economic malaise. Over the past two decades, private equity- ranging from venture capital to... View Details

      • ←
      • 21

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.